Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 176, Issue 2, Pages 228-245Publisher
WILEY
DOI: 10.1111/bph.14484
Keywords
-
Categories
Funding
- National Institutes of Health [2R01HL098032, 1R01HL125886, 5P01HL103455, T32HL110849]
- Institute for Transfusion Medicine
- Hemophilia Center of Western Pennsylvania
Ask authors/readers for more resources
Inorganic nitrate (NO3-), nitrite (NO2-) and NO are nitrogenous species with a diverse and interconnected chemical biology. The formation of NO from nitrate and nitrite via a reductive 'nitrate-nitrite-NO' pathway and resulting in vasodilation is now an established complementary route to traditional NOS-derived vasodilation. Nitrate, found in our diet and abundant in mammalian tissues and circulation, is activated via reduction to nitrite predominantly by our commensal oral microbiome. The subsequent in vivo reduction of nitrite, a stable vascular reserve of NO, is facilitated by a number of haem-containing and molybdenum-cofactor proteins. NO generation from nitrite is enhanced during physiological and pathological hypoxia and in disease states involving ischaemia-reperfusion injury. As such, modulation of these NO vascular repositories via exogenously supplied nitrite and nitrate has been evaluated as a therapeutic approach in a number of diseases. Ultimately, the chemical biology of nitrate and nitrite is governed by local concentrations, reaction equilibrium constants, and the generation of transient intermediates, with kinetic rate constants modulated at differing physiological pH values and oxygen tensions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available